To evaluate the potential for regulation of the insulin receptor substrate IRS-l, we have cloned the mouse IRS-1 gene, identified its promoter, and analyzed promoter activity in the basal state and in response to stimulation. The Y-region of the mouse IRS-1 gene lacks typical CAAT and TATA boxes but contains nine potential Spl binding sites consistent with a housekeeping gene. The 5'-region of the IRS-1 gene also has significant regions of homology with the promoters of the progesterone receptor gene, the insulin-like growth factor I receptor gene, and the androgen receptor gene. Multiple transcription start sites were identified 0.4-1.2 kilobases (kb) upstream from the start codon. Using a chloramphenicol acetyl transferase assay in Chinese hamster ovary (CHO) cells, basal promoter activity was present in the 3.2 kb 5'-flanking region of IRS-1 gene. Within this region, there were 164-base pair and 60-base pair negative regulatory elements at -3.2 kb and -1.6 kb surrounded by positive elements.
By gel shift assay, a nuclear factor was identified in CHO cells which binds to -1666 and -1666 sequence in the negative regulatory element and appears to be distinct from C/EBP, CREB, and AP-1. In 3T3-F442A adipocytes dexamethasone treatment significantly decreased IRS-1 mRNA and IRS-1 protein. This was due to a decrease in the half-life of IRS-1 mRNA, with no change in IRS-1 promoter-chloramphenicol acetyl transferase activity. Insulin also decreased IRS-1 protein by -66% within g h but did so without altering IRS-1 mRNA levels or chloramphenicol acetyl transferase activity. Thus, both insulin and dexamethasone down-regulate IRS-1 expression at the posttranscriptional level; with om-8809/95/$3 00/o Molecular Endocrmology CopyrIght Q 1995 by The Endocme Socety insulin this is probably due to an effect on protein half-life, whereas with dexamethasone the effect is due to a change in the half-life of IRS-1 mRNA. (Molecular Endocrinology 9: 1367-1379,1995)
INTRODUCTION
After insulin stimulation, the insulin receptor undergoes autophosphorylation on tyrosine residues which, in turn, activates the tyrosine kinase activity of the receptor toward other substrates. Insulin receptor substrate-l (IRS-l) (1) initially identified as pp185 (2) is the major substrate for the insulin receptor tyrosine kinase in all cells and tissues studied. IRS-l is a cytoplasmic protein that migrates between 165 and 185 kilodaltons (kDa) on sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and is tyrosine phosphorylated by the insulin receptor tyrosine kinase immediately after insulin stimulation (l-3). Based on a number of studies using mutated insulin receptors, insulin receptor tyrosine kinase activity and the phosphorylation of IRS-1 appear to be essential steps in insulin signal transduction (4-11). In 1991, using partial peptide sequences from the purified protein, we cloned the rat liver IRS-l cDNA (1, 12). More recently, we and others have cloned the human skeletal muscle IRS-l cDNA (13), the human IRS-1 gene (13, 14) and the mouse IRS-1 gene (15). The human and mouse IRS-1 genes have been shown to contain the entire coding region in a single exon. All three IRS-1 proteins are highly homologous (15). Twenty potential tyrosine phosphorylation sites, nine of which are in Tyr-Met-X-Met (YMXM) or Tyr-X-X-Met (YXXM) motifs (16). are completely conserved, and most of the potential serine/threonine phosphorylation sites are also conserved among these three species (15). Based on peptides designed from rat IRS-l, ty-1367 MOL END0 1995 END0 1368 Vol9No. 10 rosine phosphorylation of IRS-1 by the insulin receptor tyrosine kinase probably occurs with high affinity on the YMXM and/or YXXM motifs (17) and this results in binding of IRS-1 to the 85kDa subunit of phosphatidylinositol 3-kinase and other SH2 domain-containing molecules, leading to further downstream signal transduction (18, 19) .
Like other components of the early insulin response, IRS-1 is subject to a variety of regulatory influences. In animal studies, we have shown that IRS-1 protein levels are altered in fasting and streptozotocin-diabetic and oblob mice, suggesting that insulin may play some role in IRS-1 regulation (20). In 3T3-Ll cells, IRS-1 protein increases during differentiation from fibroblast to adipocytes and is negatively regulated by dexamethasone (Dex) and insulin (21). In human fetal tissues, IRS-1 mRNA is detected in every tissue examined; however, the abundance of the mRNA varies with higher expression in brain, kidney, and small intestine (13). At present, the mechanisms of regulation of IRS-1 protein, mRNA, or gene transcription are unknown. To begin to elucidate these processes, we have cloned and characterized the promoter region of the mouse IRS-1 gene, identified a nuclear factor that may be responsible for negative regulation, and used 3T3-F442A cells stably transfected with the IRS-1 promoter-chloramphenicol acetyl transferase (CAT) constructs to examine the effects of insulin and Dex on regulation of IRS-1 protein, mRNA, and gene transcriptional activity.
RESULTS

Cloning and Expression
of the Mouse IRS-1 Gene A 6.7 kilobase (kb) BarnHI-EcoRI fragment from the mouse IRS-1 gene, which contained the 5'-flanking region and a part of coding region, was subcloned into pBluescript SK-II, and the nucleotide (nt) sequence of the 3.3-kb coding region and 3.4-kb 5'-flanking region was determined (Fig. 1) . The nt sequence of the 5'-region of the mouse IRS-1 gene showed a high level of identity with that of the 5'-untranslated region of the rat IRS-1 cDNA (94.6%, Ref. 1) and human IRS-1 cDNA (82.2%, Ref. 13).
The expression of IRS-1 mRNA in different mouse tissues was assessed by Northern blot analysis using 2 pg poly(A)' RNA prepared from mouse heart, brain, spleen, lung, liver, skeletal muscle, kidney, and testis. IRS-1 mRNA appeared as a single species of 9.5 kb in most tissues and could be detected in every tissue examined after 3 days exposure at -70 C with an intensifying screen (Fig. 2) . The relative abundance of IRS-1 as compared with actin was greatest in brain, heart, lung, and kidney. We have previously shown that IRS-1 mRNA could be detected in human tissues in poly(A) t RNA blot, but not in blots prepared with IO-50 pg total RNA, suggesting a low abundance of IRS-1 mRNA in both human and rodent tissues (13). The transcription start site(s) of the IRS-1 gene were identified in primer extension experiments using five different primers (shown by arrows in Fig. 1 ). Seven major and nine minor potential transcription start sites could be found in the promoter region: all were located between 400 and 1200 base pairs (bp) upstream from ATG codon (Fig. 4 and shown by triangles under the sequence in Fig. 1 ). The start sites of rat (1) and human (13) IRS-1 cDNAs (shown by open circle and asterisk in Fig. 1 , respectively) are close to the possible transcription start sites at positions -610, -1072, and -1079.
To determine the mechanisms of transcriptional and COS ceils is similar to that of pSVOOCAT and about 20% that of pSVOCAT (22,23) (data not shown). As shown in Fig. 3A , the CAT plasmid that has the 3.2 kb of mouse IRS-1 gene in the correct orientation (plRSBa-CAT) had significant promoter activity and was 25-30 times more active than the CAT plasmid that contained the same fragment in the reverse orientation (plRSBaR-CAT).
This construct of the mouse IRS-1 promoter, however, was less active than the human insulin receptor promoter in CHO cells (24, 25) .
Based on sequence analysis of the promoter region, there was no typical TATA box or CAAT box, but there were nine potential Spl transcription factor-binding sites [GGGCGG, shown in shaded boxes in higher than that of plRSSp-CAT but significantly some transcription start sites (Fig. 3C ). Thus, there lower than that of plRSBg-CAT ( kinase. Poly(A)+ RNA (5 pg) prepared from mouse liver or yeast tRNA (as a control) was mixed with 2 pmol labeled primer and subjected to the analysis. To directly compare the products with the genomic nt sequence, the sequence reaction was performed using the same primer that had been used for primer extension and electrophoresed in 6% urea-acrylamide gels with the product of primer extension. A representative result is shown. Large and small arrowheads show the major and minor transcription start sites, respectively.
-3369 and -3185 and between -1645 and -1585 in promoter region of the mouse IRS-1 gene (Fig.  3C ). 
Gel Shift Assay of the Negative Regulatory Region
To further analyze the negatively acting &-acting element between -1645 and -1585 bp of the IRS-1 gene, we performed gel shift assays. Using a probe that corresponded to the -1606 to -1586 bp region, a single retarded band was observed in the presence of the nuclear extract of CHO cells (Fig. 5, lane 2) . This band was competed out by adding the excess of cold probe (Fig. 5, lane 3) but was not competed out by addition of the competitors with the consensus sequences of C/EBP, CREB, and AP-1 binding sites (Fig.  5, lanes 4-6) . By comparison, no retarded band was observed in the gel shift assay using a probe corresponding to base -1646 to -1606 (data not shown). These data indicate that there is a nuclear factor in CHO cells that binds to the sequence between the -1606 and -1596-bp region of the mouse IRS-1 promoter, negatively regulates IRS-1 expression, and is distinct from WEBP, CREB, and AP-1.
Stable 3T3-F442A
Transfectants with IRS-1 Promoter-CAT Constructs
To understand the mechanisms of regulation of IRS-1 expression, the protein, mRNA, and promoter activity of IRS-l were analyzed in 3T3-F442A cells stably transfected with a mouse IRS-1 promoter-CAT gene fusion plasmid. Two independent clones (3T3lRSCAT-5 and 3T3lRSCAT-14) were used for this analysis to avoid artifacts due to clonal variability and variability of the integration site of the transfected plasmid.
In 3T3-F442A cells, IRS-1 was detected as a single band of -170 kDa on immunoblots after SDS-PAGE under reducing conditions.
After acute insulin stimulation, the IRS-l band was shifted to an apparent higher molecular weight, probably due to the increased phosphorylation of the protein (1,21). Upon prolonged stimulation with 10m6 M insulin, IRS-1 protein decreased in a time-dependent manner with a -50% reduction by 6 h (P < 0.05) (Fig. 6A and Fig.  8 , filled circle). Dexamethasone (1O-6 M) treatment also decreased the amount of IRS-1 significantly by up to -60% in 9 h (P < 0.01) ( Fig. 6B and Fig. 9 , filled circle); however, the kinetics of the IRS-l decrease were somewhat different with the two hormones. IRS-1 protein decreased rapidly after insulin stimulation with a significant reduction already detected at 30 min, whereas with Dex IRS-l increased initially at 30'min and 1 h after stimulation and then started to decrease at 3 h (cempare Figs. 8 and 9, filled circles). These differences in kinetics suggest different mechanisms of hormonal regulation of the IRS-l protein.
Effects of Hormones on IRS-1 mRNA
Since IRS-l mRNA is of very low abundance, mRNA levels were estimated in semiquantitative reverse transcriptase-polymerase chain reaction (RT-PCR) with labeled primers and autoradiography. Products of the expected sizes were observed for both IRS-1 (221 bp) and &-microglobulin (136 bp) used as an internal standard.
Although the IRS-l sequence is derived from a single exon, PCR in the absence of reverse transcription revealed negligible contamination of genomic DNA (data not shown). The amount of &-microglobulin mRNA was quite constant from experiment to experiment. After either acute or chronic insulin stimulation, there was no significant change in IRS-l mRNA ( Fig. 7A and Fig. 8 , filled triangles). By contrast, IRS-1 mRNA decreased significantly upon stimulation with Dex, reaching 60% of basal levels within 3 h (P < 0.05) (Figs. 78 and 9, filled triangles). The decrease in IRS-1 mRNA with Dex began by 60 min and preceded the decrease in IRS-1 protein levels. Neither insulin (Fig. 8 , filled squares) nor Dex (Fig. 9, filled . . ,: :,:: :\:'. Northern blot analysis revealed that IRS-1 mRNA is expressed in every tissue mRNA, supporting the notion that the IRS-1 gene is a housekeeping gene. However, expression of IRS-1 mRNA varied between tissues and was highest in brain, heart, lung, and kidney, which interestingly, except for the heart, are tissues not viewed as classic metabolic targets for insulin action. We have previously analyzed the abundance of the IRS-1 mRNA in human fetal tissues by a quantitative RT-PCR method (13). Human IRS-1 mRNA was most abundant in brain, kidney, and small intestine and was less abundant in liver and skeletal muscle. Thus, the tissue distribution in mice is similar to that in humans. Studies using immunocyto- By primer extension analysis, six major and nine minor possible transcription start sites were identified. Multiple transcription start sites have also been reported for the human epidermal growth factor (EGF) receptor (41) and insulin receptor genes (42), which also lack typical TATA and CAAT boxes but possess multiple Spl -binding sites. Although it was not possible to confirm these transcription start sites by Sl mapping analysis due to the low abundance of the IRS-1 mRNA, the primer extension experiments were reproducible.
The fact that the start sites of rat and human IRS-1 cDNAs mapped among these possible transcription start sites also supports these results. The analysis of the transcriptional activity of the 5'-region was performed employing deletion analysis of plRSBa-CAT transiently expressed in CHO cells. Two negatively and two positively acting regions could be mapped by this analysis. In one of the negatively acting region localized between -3369 and -3185, there are two overlapping inverted repeats and one possible glucocotticoid response element which has reported to regulate the expression negatively (GRE-, Ref. 30). By deletion analysis, we could also map a 60-bp region between -1645 and -1586 bp involved in negative regulation of the mouse IRS-1 promoter. In this region, there is one AP-1 and one WEBP putative binding site (see Fig. 1) . To identify the possible transcription factor(s) that may be responsible for the negative regulation of the IRS-l gene transcription, we performed gel shift assay using probes corresponding to -1606 to -1586 bp (probe 1) and -1645 to -1607 bp (probe 2) of this region. In this assay, we could identify a nuclear factor that binds to the probe 1. Since this binding was not competed for by addition of excess amounts of C/EBP, WEB, and AP-1 consensus sequences, this factor seems to be distinct from these factors. Further analysis is necessary to characterize this factor, which appears to be responsible for the negative regulation ofthe IRS-1 gene transcription.
Computer analysis of the 5'-flanking region of the mouse IRS-1 gene revealed an 814-nt region with 52% identity to the 5'-region of chicken progesterone receptor gene (35), a 374-nt overlap with 56% identity to the human insulin-like growth factor I receptor promoter (36) and a 59% identity in a 170-nt overlap with the 5'-region of the human androgen receptor gene (37). The homology domain of the mouse IRS-l gene (-1248 to -466) and of the chicken progesterone receptor gene (35) (-212 to +583) includes one AGrich region and several possible transcription start sites. The chicken progesterone receptor gene has been reported to code for two forms (A and B) of the receptor using two different ATG codons (19, 35, 43). The ATG for form B of the chicken progesterone receptor gene is included in this homology domain; thus the sequence of chicken progesterone receptor gene shown here represents a part of the promoter for the A form of the receptor (35,43,44) .
The high homology of the 5'-region of the mouse IRS-1 gene with those of chicken progesterone receptor gene and other hormone receptor genes may indicate that these genes are regulated in a similar manner. Further analysis of this point is necessary.
To study the hormonal regulation of IRS-l in an insulin-sensitive cell line, we used the well characterized 3T3-F442A cells. This cell line is known to be differentiated to adipocytes after stimulation by insulin, Dex, or both. Since IRS-1 mRNA is not plentiful (13), we used the RT-PCR method and CAT assay to study the IRS-l mRNA level and transcriptional regulation of IRS-1 gene. The mouse IRS-l promoter-CAT gene fusion plasmid (plRSBa-CAT) used for these studies was constructed from an improved low background vector (22) that had been successfully used for the analysis of several promoters with relatively low activity (23, 45). Since it is difficult to transfect the differentiated adipocytes, the 3T3-F442A were stably transfected with plRSBa-CAT as fibroblasts and differentiated to adipocytes before study. (3T3lRSCAT-5 and 3T3lRSCAT-14) were used for the analysis.
Northern
Blot Analysis of Mouse IRS-1
Insulin significantly decreased IRS-1 protein in 3T3-F442A cells in a relatively short time (30 min') but did not change the amount of IRS-1 mRNA or promoter activity as measured in the CAT assay. Thus, the decrease of IRS-1 protein is likely due to decreased half-life of IRS-1 protein and/or increased degradation of IRS-1 possibly due to posttranslational modification of the protein. Regulation of IRS-1 in 3T3-Ll adipocytes by insulin has also been studied by Rice et al. (21. 46) . who have found that insulin stimulates the degradation of IRS-1 protein in 3T3-Ll adipocy-tes. They have shown that the half-life of IRS-1 protein is about 25 h in the basal state and decreases to 2.5 h in the presence of 1 PM insulin (46). They have also shown that the insulin-induced down-regulation of IRS-1 protein occurs in the presence of cycloheximide. Our data are consistent with these observations and further support that insulin has no effect on IRS-l mRNA level and IRS-1 gene promoter activity.
A portion (2.6 kb) of mouse IRS-1 gene coding region (16-2581 nt, in Ref. 15) was isolated, 32P labeled using an oligolabeling kit (Pharmacia, Piscataway, NJ), and used as a probe (1 O6 cpm/ml).
A multiple tissue Northern (MTN) blot (CLON-TECH, Palo, Alto, CA) on which 2 pg of poly(A)+ RNA from eight different mouse tissues were subjected to analysis was used following recommendations of the manufacturer. The same blot was reprobed with the p-actin cDNA (48) as a control.
Analysis of the Transcription Start Sites
Poly(A)+ RNA was prepared from mouse liver using the RNAzol B (Biotecx Laboratories, Houston, TX) followed by oligo (dT) cellulose chromatography.
Five different oligonucleotides synthesized complementary to the 5'-region of the gene were end labeled with [r3*P]ATP using T4 polynucleotide kinase. Five micrograms of poly(A)+ RNA or yeast RNA (as a control)
were mixed with 2 pmol labeled primer and heated at 95 C for two min, chilled on ice, and annealed at 37 C for 30 min and then subjected to a reverse transcription reaction.
To directly compare these products with the genomic nt sequence, the sequence reaction was performed as described above using the same primer that had been used for primer extension and electrophoresed in a 6% ureaacrylamide gel with the products of the primer extension reaction.
Dexamethasone also decreased the level of IRS-l protein; however, the mechanism of the down-regulation in this case appears to be different. Dexamethasone decreased the IRS-1 mRNA, as well as protein, without changing the IRS-1 promoter activity. Furthermore, Dex decreased IRS-1 mRNA half-life to almost one third of control levels. The decrease in IRS-l mRNA started at 1 h after stimulation with Dex and preceded the decrease in IRS-1 protein, which was first detected after 2 h of stimulation. This delay could be explained by the time required for IRS-1 translation from mRNA to protein. Taken together, the downregulation of IRS-l produced by glucocorticoids is due mainly to a decrease in IRS-1 mRNA half-life. Although the sequencing analysis of IRS-1 promoter region suggests potential GREs and IREs, the promoter activity as measured in the CAT assay in 3T3-F442A adipocytes did not confirm a significant regulation by insulin or Dex. Further analysis, including cotransfection with glucocorticoid receptor cDNA and use of other cell types, will be needed to characterize those potential &-acting elements.
MATERIALS AND METHODS
Construction of the IRS-1 Promoter CAT Gene Fusion Plasmids
For the analysis of the 5'-flanking region of the mouse IRS-l gene, a low background promoterless CAT plasmid with multicloning sites (5'-Sacl-Nru I-/-/indlll-Xhol-Sphl-Kpnl-Bg/llEcoRV-3') named pSVOOlCAT was constructed. Two synthetic oligonucleotides (5'-AGCTGAGCTCTCGCGAGCl-TCTCGAGCATGCGGTACCAGAl'CTGAT ATC-3', 5'-AGCTGATATCAGATCTGGTACCGCATGCTCGAGAAGCTT-CGCGAGAGC TC-3') were annealed and inserted at the Hindill site of pSVOOCAT (22). A 3.2-kb fragment was isolated by BamHl and Tthl 11 I digestion from the 5'-region of the IRS-l gene, blunt-ended using the Klenow fragment of DNA polymerase I, and inserted at the EcoRV site of pSVOO1 CAT. The resultant plasmids, which contained the 5'-region fragment in the correct orientation and reverse orientation, were named plRSBa-CAT and plRSBaR-CAT, respectively. 5'-Deletions of the mouse IRS-l gene were made by excising the fragments from plRSBa-CAT using restriction enzymes that cut the polylinker and mouse IRS-1 gene insert fragment (Kpnl, Sphl, Bglll and Xhol); the resulting constructs were named plRSKp-CAT, plRSSp-CAT, plRSBg-CAT, and plRSXh-CAT, respectively.
For the construction of plRSBs-CAT, plRSSp-CAT was digested with HindIll (in the polylinker of pSVOO1 CAT) and BspEl, blunt-ended using Klenow fragment of DNA polymerase I, and self-ligated.
Cloning and 5'-CCGGAAAGGACTTCTGAGC-CAGTCTTCCACCTGGAATCT-3', probe 2) of the IRS-l gene were used as probes.
Both probes were end labeled with [Y-~*P]ATP using T4 polynucleotide kinase before analysis. Nuclear extract was purified from the CHO cells as previously described (50). Competitors corresponding to the C/EBP, CREB, and AP-1 binding sites were designed according to the previously reported consensus sequences (for C/EBP, 5'-GATCCAAATGTAGTC-l-TATGCAATACACACl-TGTAGTClT-GCAACAG-3' and, 5'-GATCCTGTTGCAAGACTACAAGTG-TATTGCATAAGACTACATTTG-3' (51). for CREB. 5'-GATC-CTCCT-TGGCTGACGTCAGAGAGAGAG-3' and 5'-GACTC-TCTCTCTCTGACGTCAGCCAGGAG-3' (52), and for AP-1, 5'-GATCCGCCGCAAGTGACTCAGCGCGGGG-3' and 5'-GATCCCCCGCGCTGAGTCACT-TGCGGCG-3' RNA was prepared from the cells using RNAzol B, then treated with RNAase-free DNAase followed by phenol/chloroform extraction and ethanol precipitation. One microgram of each RNA sample was reverse transcribed using two 3'-primers (from IRS-l and p2 microglobulin; 1 pmol of each primer per reaction), then used for PCR. For each PCR reaction, one twentieth of the total cDNA was used as a template. Before the PCR reaction, the primers were 32P end labeled as described by Wang et al. (55) omitting the step to remove the unincorporated nt. The final PCR conditions were 10 pmol of each primer per reaction, denaturing at 94 C for 30 set, annealing at 57 C for 30 set, and extension at 72 C for 1 min. Linear amplification of IRS-l and p2-microglobulin mRNA was achieved using 50 ng total RNA per reaction and 21 to 27 cycles; amplification was also linear in both RT-PCR and PCR methods over a wide range of total RNA per PCR reaction (0.0156-0.25 yg) and l-500 attomoles of IRS-l cDNA per PCR reaction (data not shown). The final PCR products were separated on a 5% acrylamide gel in 0.5 x TBE buffer, and gels were dried and subjected to autoradiography. The appropriate bands were cut from the gel, and the radioactivity was determined by Cerenkov counting. 
